Lipocine Inc.

US$1.57As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LPCNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (29.82%)
Div yield —
ROE (52.86%)
Biotechnology
Beta (5Y) 0.50
PE TTM —
TSR TTM (40.98%)
Mkt cap US$12.94M
ROIC (35.52%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.51
(3.77%)
(31.01%)
Hold 4|10|8|10|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
8.81%
(3.88%)
5.85%
(2.64%)
Revenue$M
0.587
0.609
0.596
0.609
2.59%
0.51%
0.47%
4.06%
Peers (US$12.94M)
Cap (US$)
PE
12.87M
—
12.79M
—
Capital
TTM
5Y
10Y
Leveragex
0.424
0.651
0.613
EBIT/Intx
0.682
0.249
0.237
Own earn%
107.58
93.95
55.61
Sh yield%
28.20
43.18
43.12
Owners
Insiders/Inst%
8.33
84.90
Short interest%
4.27
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–11
$1 testx
0.1
Incr. ROIC%
9